BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Year-over-year revenue growth rate
3Y CAGR
+9.2%/yr
Annual compound
Percentile
P79
Within normal range
vs 3Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 94.10% |
| 2024 | 36.00% |
| 2023 | 22.37% |
| 2022 | 72.31% |
| 2021 | 782.38% |
| 2020 | -63.53% |
| 2019 | 136.45% |
| 2018 | -18.00% |
| 2017 | -4.43% |
| 2016 | -45.39% |